PHT Expands Executive Roster to Support Continued Aggressive Growth in ePRO Industry

BOSTON, MA--(Marketwire - November 27, 2007) - PHT Corporation continues its strong growth as
the leader in the electronic patient reported outcome (ePRO) industry. PHT,
the market-leading provider of ePRO solutions used in more than 330
clinical trials worldwide, today announced the appointment of Ian McLeod as
Vice President of Development, and the promotion of Sheila Rocchio to Vice
President of Marketing. Mr. McLeod and Ms. Rocchio are based at PHT's U.S.
headquarters in Boston, MA, and report directly to PHT President and CEO
Phil Lee.

Mr. McLeod's responsibilities include advancing technical development and
vision by prioritizing the roadmap for new and expanded ePRO products and
features. He is a Computer Engineering graduate of Lehigh University and
holds a Masters of Engineering degree from Rensselaer Polytechnic
Institute. Mr. McLeod has over 20 years of experience in leading large
software development projects and organizations. Mr. McLeod previously was
a Vice President at Borland Software, where he led the integration of Segue
Software.

"I was attracted to PHT because it is at an inflection point with its
tremendous growth and consistent positive earnings," said Mr. McLeod. "I
look forward to working with PHT's talented team to continue the trend of
balancing tactical support of current products with innovation for the ePRO
industry as a whole."

During Ms. Rocchio's seven-year tenure at PHT, she has created the Product
Management department and held global responsibilities for positioning,
branding, communications and event management as PHT emerged as the clear
ePRO market leader. Formerly the Executive Director of Marketing, Ms.
Rocchio holds a Bachelor of Science from the Massachusetts Institute of
Technology and an MBA from Boston College.

"Everyone at PHT has great enthusiasm and belief in our vision and
mission," explained Ms. Rocchio. "The work we do has an invaluable impact
on the lives of patients around the world. We play a critical role in the
process of eradicating disease by enabling the collection of high quality
data directly from patients, which yields faster and more conclusive trial
results. It is an important time in the industry, and I look forward to
helping PHT continue its impressive growth."

Mr. Lee said, "The creation of these two executive positions is a milestone
in the growth and progress of PHT. Ian's experience and background
successfully managing large-scale development initiatives are great assets
as we advance the benefits and possibilities of ePRO. Sheila's knowledge of
the eClinical market, our products and customer requirements further
reinforces the value of our client-centric strategy. The Board and I
welcome both professionals to their new roles, and we are excited for what
the future holds."

About PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome
(ePRO) solutions used in more than 330 clinical trials around the world.
The company's proven LogPad® and StudyPad® Systems deliver the voice of
the patient -- directly and without distortion -- with reliable and timely
self-reported data. Patient experiences captured firsthand by PHT's ePRO
Product Suite have been used successfully in at least eight NDA
submissions, with five known approvals, to date. To learn more about how
study sponsors worldwide are using ePRO to improve data quality, conduct
smaller trials, and manage patient safety, enrollment and compliance in
real time, visit www.phtcorp.com.

PHT, LogPad and StudyPad are among the registered trademarks and trademarks
of PHT Corporation.